Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Brian Koss

Concepts (153)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms, Experimental
2
2020
111
0.810
Why?
Small Molecule Libraries
3
2019
67
0.760
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2020
60
0.700
Why?
Lymphocytes, Tumor-Infiltrating
1
2020
75
0.690
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
2016
10
0.630
Why?
Biomimetic Materials
1
2016
10
0.530
Why?
Proto-Oncogene Proteins
1
2016
155
0.500
Why?
Histones
3
2024
295
0.490
Why?
Peptide Fragments
1
2016
207
0.490
Why?
Cell Lineage
2
2014
83
0.460
Why?
Melanoma
3
2023
281
0.450
Why?
Fusion Proteins, bcr-abl
1
2013
19
0.440
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2013
84
0.410
Why?
Mice
13
2023
5658
0.380
Why?
Cell Line, Tumor
6
2020
1388
0.340
Why?
Apoptosis
8
2023
1092
0.340
Why?
Neoplasms
4
2024
1233
0.330
Why?
Proto-Oncogene Proteins c-bcl-2
4
2014
126
0.310
Why?
Animals
14
2024
13100
0.300
Why?
Antineoplastic Agents
3
2023
1175
0.290
Why?
Ubiquitination
2
2024
40
0.250
Why?
Tumor Microenvironment
3
2023
221
0.240
Why?
Antigen Presentation
1
2023
25
0.220
Why?
Chromatin
1
2024
137
0.220
Why?
Gene Rearrangement
1
2024
73
0.220
Why?
Mice, Transgenic
2
2016
543
0.210
Why?
DNA-Activated Protein Kinase
1
2023
22
0.210
Why?
Cell Survival
5
2019
590
0.210
Why?
Mice, Inbred C57BL
4
2016
1777
0.200
Why?
DNA Damage
1
2024
298
0.200
Why?
Leukemia, Myeloid, Acute
1
2024
179
0.200
Why?
Disease Progression
1
2024
820
0.190
Why?
Hematologic Neoplasms
1
2023
98
0.190
Why?
Tumor Suppressor Protein p53
1
2023
213
0.190
Why?
Histone Code
2
2020
30
0.180
Why?
Epigenesis, Genetic
2
2020
370
0.170
Why?
Transcription Factors
2
2023
565
0.170
Why?
Xenograft Model Antitumor Assays
2
2019
212
0.160
Why?
Polycomb Repressive Complex 2
1
2019
46
0.160
Why?
Integrin alpha Chains
1
2019
9
0.160
Why?
Tumor Cells, Cultured
2
2019
462
0.160
Why?
Cell Cycle Checkpoints
1
2019
30
0.160
Why?
Melanoma, Experimental
1
2019
40
0.160
Why?
Cadherins
1
2019
64
0.160
Why?
Humans
17
2024
49898
0.150
Why?
Antigens, CD
1
2019
215
0.150
Why?
CTLA-4 Antigen
1
2017
23
0.140
Why?
Programmed Cell Death 1 Receptor
1
2017
40
0.140
Why?
DNA-Binding Proteins
1
2019
424
0.140
Why?
Transfection
1
2016
354
0.120
Why?
CASP8 and FADD-Like Apoptosis Regulating Protein
1
2014
1
0.120
Why?
Granulocytes
1
2014
26
0.120
Why?
Myeloid Cells
1
2014
37
0.120
Why?
Drug Resistance, Neoplasm
1
2017
314
0.120
Why?
Protein Processing, Post-Translational
2
2020
154
0.120
Why?
CD8-Positive T-Lymphocytes
3
2023
124
0.120
Why?
Monocytes
1
2014
131
0.110
Why?
Gene Expression Regulation, Leukemic
1
2013
31
0.110
Why?
Antibodies, Monoclonal
1
2017
457
0.110
Why?
Lung Neoplasms
1
2019
600
0.110
Why?
Cells, Cultured
2
2013
1587
0.100
Why?
High-Throughput Screening Assays
1
2012
35
0.100
Why?
B-Lymphocytes
1
2013
175
0.100
Why?
Mitochondria
2
2013
395
0.100
Why?
Peptides
1
2012
220
0.100
Why?
Ubiquitin
1
2010
45
0.090
Why?
Ubiquitin-Protein Ligases
2
2024
93
0.080
Why?
Disease Models, Animal
1
2013
1411
0.080
Why?
T-Lymphocytes
2
2023
328
0.080
Why?
Gene Expression Regulation, Neoplastic
2
2024
824
0.070
Why?
Structure-Activity Relationship
2
2019
394
0.060
Why?
Multiple Myeloma
1
2019
2915
0.060
Why?
Camptothecin
1
2024
16
0.060
Why?
BRCA1 Protein
1
2024
30
0.060
Why?
Myeloid-Lymphoid Leukemia Protein
1
2024
14
0.060
Why?
Proto-Oncogenes
1
2024
27
0.060
Why?
Major Histocompatibility Complex
1
2023
12
0.060
Why?
Cell Proliferation
2
2019
986
0.060
Why?
Interferons
1
2023
38
0.060
Why?
HEK293 Cells
1
2024
216
0.060
Why?
Histocompatibility Antigens Class I
1
2023
44
0.060
Why?
Proto-Oncogene Proteins c-ret
1
2024
33
0.060
Why?
Cell Transformation, Neoplastic
1
2024
181
0.050
Why?
HLA Antigens
1
2023
53
0.050
Why?
Adaptor Proteins, Signal Transducing
1
2024
197
0.050
Why?
Cell Cycle Proteins
1
2024
167
0.050
Why?
DNA Repair
1
2024
185
0.050
Why?
Cell Respiration
2
2013
41
0.050
Why?
Microscopy, Electron, Transmission
2
2013
75
0.050
Why?
Antigens, Neoplasm
1
2023
146
0.050
Why?
Phosphorylation
1
2024
526
0.050
Why?
Protein Kinase Inhibitors
1
2024
205
0.050
Why?
CD4-Positive T-Lymphocytes
1
2023
157
0.050
Why?
Immunotherapy, Adoptive
1
2023
158
0.050
Why?
Proteomics
1
2023
292
0.050
Why?
Promoter Regions, Genetic
1
2023
467
0.040
Why?
Workflow
1
2020
51
0.040
Why?
DNA
1
2023
543
0.040
Why?
Azepines
1
2019
19
0.040
Why?
Oxidative Stress
1
2024
759
0.040
Why?
Methylation
1
2019
118
0.040
Why?
Molecular Dynamics Simulation
1
2019
34
0.040
Why?
Mice, Inbred NOD
1
2019
94
0.040
Why?
Crystallography, X-Ray
1
2019
148
0.040
Why?
Mice, SCID
1
2019
173
0.040
Why?
Drug Evaluation, Preclinical
1
2019
145
0.040
Why?
Protein Structure, Tertiary
1
2019
249
0.040
Why?
Binding Sites
1
2019
378
0.040
Why?
Membrane Potential, Mitochondrial
1
2016
39
0.030
Why?
Immunoprecipitation
1
2016
58
0.030
Why?
Epithelial-Mesenchymal Transition
1
2017
49
0.030
Why?
bcl-X Protein
1
2016
52
0.030
Why?
Drug Design
1
2016
119
0.030
Why?
Drug Discovery
1
2016
83
0.030
Why?
Proteome
1
2017
153
0.030
Why?
Fas-Associated Death Domain Protein
1
2014
6
0.030
Why?
Caspase 8
1
2014
10
0.030
Why?
Minor Histocompatibility Antigens
1
2014
17
0.030
Why?
Neoplasm Transplantation
1
2014
84
0.030
Why?
Immune Tolerance
1
2014
84
0.030
Why?
Coculture Techniques
1
2014
143
0.030
Why?
RNA, Small Interfering
1
2014
210
0.030
Why?
Mice, 129 Strain
1
2013
37
0.030
Why?
bcl-2 Homologous Antagonist-Killer Protein
1
2013
18
0.030
Why?
bcl-2-Associated X Protein
1
2013
53
0.030
Why?
Sequence Deletion
1
2013
69
0.030
Why?
Proton-Translocating ATPases
1
2012
9
0.030
Why?
Oxygen Consumption
1
2013
188
0.030
Why?
Membrane Potentials
1
2012
117
0.020
Why?
Mice, Knockout
1
2014
835
0.020
Why?
Cell Differentiation
1
2014
649
0.020
Why?
Models, Molecular
1
2012
334
0.020
Why?
Adenosine Triphosphate
1
2012
231
0.020
Why?
Child
1
2023
6844
0.020
Why?
Hematopoietic System
1
2010
3
0.020
Why?
Myocardium
1
2013
443
0.020
Why?
Leupeptins
1
2010
7
0.020
Why?
Cycloheximide
1
2010
39
0.020
Why?
Embryo, Mammalian
1
2010
67
0.020
Why?
Mutant Proteins
1
2010
37
0.020
Why?
Protein Stability
1
2010
42
0.020
Why?
Half-Life
1
2010
85
0.020
Why?
Alleles
1
2010
251
0.020
Why?
Treatment Outcome
1
2020
5176
0.020
Why?
Proteasome Inhibitors
1
2010
104
0.020
Why?
Dose-Response Relationship, Drug
1
2012
1354
0.020
Why?
Fibroblasts
1
2010
352
0.020
Why?
Signal Transduction
1
2014
1608
0.020
Why?
Heart Failure
1
2013
505
0.020
Why?
Muscle, Skeletal
1
2013
769
0.020
Why?
Cell Line
1
2010
1010
0.020
Why?
Mutation
1
2010
1292
0.010
Why?
Female
1
2019
26560
0.010
Why?
Koss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description